0001867067-21-000002.txt : 20210723 0001867067-21-000002.hdr.sgml : 20210723 20210723172429 ACCESSION NUMBER: 0001867067-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210723 DATE AS OF CHANGE: 20210723 EFFECTIVENESS DATE: 20210723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Slingshot Biosciences, Inc. CENTRAL INDEX KEY: 0001867067 IRS NUMBER: 454546594 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-402858 FILM NUMBER: 211111687 BUSINESS ADDRESS: STREET 1: 1250 45TH STREET, SUITE 330 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 770-6806 MAIL ADDRESS: STREET 1: 1250 45TH STREET, SUITE 330 CITY: EMERYVILLE STATE: CA ZIP: 94608 D/A 1 primary_doc.xml X0708 D/A LIVE 0001867067 Slingshot Biosciences, Inc. 1250 45TH STREET, SUITE 330 EMERYVILLE CA CALIFORNIA 94608 (510) 770-6806 DELAWARE None None Corporation true Jeffrey Kim c/o Slingshot Biosciences, Inc. 1250 45th Street, Suite 330 Emeryville CA CALIFORNIA 94608 Executive Officer Director Ronald J. Silberman c/o Slingshot Biosciences, Inc. 1250 45th Street, Suite 330 Emeryville CA CALIFORNIA 94608 Director Adam Wieschhaus c/o Slingshot Biosciences, Inc. 1250 45th Street, Suite 330 Emeryville CA CALIFORNIA 94608 Director Corey Ritter c/o Slingshot Biosciences, Inc. 1250 45th Street, Suite 330 Emeryville CA CALIFORNIA 94608 Director Other Decline to Disclose 06b true 0001867067-21-000001 2021-05-28 false true false 0 22879969 22879969 0 Series A-1 Preferred Stock, Series A-2 Preferred Stock and the common stock issuable upon conversion thereof. false 17 0 0 0 false Slingshot Biosciences, Inc. /s/Jeffrey Kim Jeffrey Kim Chief Executive Officer 2021-07-23